Pershing Square Invests $900 Million in Howard Hughes Holdings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Source: stocktwits
- Significant Investment: Pershing Square announced a substantial investment of $900 million in Howard Hughes Holdings by purchasing 9 million shares, demonstrating strong confidence and support for the company’s transformation and growth strategy.
- Fee Structure: As part of the deal, Howard Hughes will pay Pershing Square a quarterly base fee of $3.75 million along with a management fee based on any increase in the company's equity market capitalization, providing a stable revenue stream that enhances Pershing Square's financial flexibility.
- Executive Appointments: Bill Ackman has been appointed as the Executive Chairman of the Howard Hughes Board, while Pershing Square's Chief Investment Officer Ryan Israel will assume the same role at Howard Hughes, strengthening strategic alignment and resource integration between the two firms.
- Positive Market Reaction: Citi initiated coverage of Pershing Square with a 'Buy' rating and a $50 price target, implying over 40% potential upside, while PS shares rose nearly 1% in Tuesday's pre-market session, reflecting optimistic market sentiment regarding this investment.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PS
Wall Street analysts forecast PS stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 36.000
Low
Averages
High
Current: 36.000
Low
Averages
High
About PS
Pershing Square Inc. is an alternative asset manager. It manages three primary investment funds, which it refer to as its existing core funds. Its fund investors include retail investors, high net worth individuals, family offices, funds of funds, and institutional investors. Its core investment strategy involves acquiring large minority stakes in high-quality, predominantly North American-listed, large-capitalization growth companies at attractive valuations during periods in which they have underperformed their potential and/or when they are undervalued because the market underestimates their potential or overestimates the impact of certain negative factors on their businesses. In addition, it manages two private funds, Pershing Square, L.P. (PSLP) and Pershing Square International, Ltd. (PSINTL).
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Strong IPO Performance: Pershing Square's stock has surged over 27% since its IPO nearly a month ago, although analysts express concerns about its current valuation, indicating market recognition of its asset management model.
- Significant Fundraising: The IPO raised $5 billion alongside the closed-end fund Pershing Square USA, pricing at the lower end of analysts' expectations, yet demonstrating strong investor interest.
- Divergent Analyst Ratings: While most analysts maintain neutral ratings with price targets between $37 and $42, Citi has issued a buy rating with a target of $50, suggesting approximately 40% upside potential.
- Long-Term Growth Potential: Analysts generally believe that Pershing Square possesses high-quality asset management capabilities and stable revenue streams, and despite its elevated valuation, its unique investment model and brand strength may drive long-term NAV growth.
See More
- Analyst Coverage Initiation: Wall Street analysts have initiated coverage on Bill Ackman's Pershing Square (PS.N) following the end of the quiet period after its recent IPO, primarily assigning neutral ratings that reflect a cautious market sentiment.
- Long-Term Return Potential: Analysts noted that while Pershing Square demonstrates strong long-term return potential and a scalable business model, they also emphasized that much of the upside is already priced in, indicating a cautious outlook on future growth.
- Strong Underwriter Lineup: The global coordinators and bookrunners for the IPO include Citigroup, UBS Securities, BofA Securities, Jefferies, and Wells Fargo, showcasing a high level of market recognition and professional support for the transaction.
- Muted Market Reaction: Despite analysts' neutral stance on Pershing Square's prospects, the market reaction has been relatively subdued, suggesting that investors remain cautious about the company's future performance, which may impact its short-term stock price.
See More
- Analyst Rating Overview: Following the April 29 IPO of Ackman's Pershing Square, Wall Street analysts predominantly assigned a Hold rating to the stock, recognizing its business model and high margins, yet noting that its current valuation reflects these strengths.
- Capital Structure Advantage: Jefferies highlighted that approximately 96% of Pershing Square's fee-paying capital is classified as permanent, which mitigates redemption-related outflows and distinguishes it from peers, although its valuation remains above industry averages.
- Potential Risk Factors: BofA analysts pointed out that Ackman's involvement could pose a risk if he reduces his engagement due to retirement or political ambitions, while the concentrated portfolio also presents inherent risks.
- Short-term Catalysts: Citi analysts see potential for short-term upside in asset gathering or performance, particularly regarding the yet-to-be-realized value associated with Howard Hughes-related fees, which could enhance market sentiment.
See More
- Vipshop Rating Upgrade: UBS upgraded Vipshop (VIPS) from Neutral to Buy, indicating that despite near-term growth pressures, the company's earnings quality and shareholder returns are more attractive, showcasing resilience in a competitive e-commerce landscape.
- Seaport Therapeutics Initiation: JPMorgan initiated coverage on Seaport Therapeutics (SPTX) with an Overweight rating and a price target of $42 for December 2027, reflecting bullish sentiment and highlighting the company's potential for growth in the biotech sector.
- Apple Price Target Increase: Bank of America raised its price target on Apple (AAPL) from $330 to $380, emphasizing significant opportunities in agentic AI, while reiterating a Buy rating, which underscores confidence in the company's future growth trajectory.
- Dave Inc. Initial Rating: UBS initiated coverage on Dave Inc. with a Buy rating and a price target of $300, suggesting that the market underestimates the durability of its high-velocity credit model and earnings growth trajectory, indicating strong future potential.
See More
- Significant Investment: Pershing Square announced a substantial investment of $900 million in Howard Hughes Holdings by purchasing 9 million shares, demonstrating strong confidence and support for the company’s transformation and growth strategy.
- Fee Structure: As part of the deal, Howard Hughes will pay Pershing Square a quarterly base fee of $3.75 million along with a management fee based on any increase in the company's equity market capitalization, providing a stable revenue stream that enhances Pershing Square's financial flexibility.
- Executive Appointments: Bill Ackman has been appointed as the Executive Chairman of the Howard Hughes Board, while Pershing Square's Chief Investment Officer Ryan Israel will assume the same role at Howard Hughes, strengthening strategic alignment and resource integration between the two firms.
- Positive Market Reaction: Citi initiated coverage of Pershing Square with a 'Buy' rating and a $50 price target, implying over 40% potential upside, while PS shares rose nearly 1% in Tuesday's pre-market session, reflecting optimistic market sentiment regarding this investment.
See More
- Coverage Initiation: Jefferies has initiated coverage on Pershing Square USA (PSUS) with a Buy rating and Pershing Square Inc. (PS) with a Hold recommendation, as analyst Matthew Hose believes PSUS will benefit from a strong performance track record and attractive valuation.
- Performance Comparison: PSUS is expected to mirror the performance of other Pershing Square core funds, which have outperformed the S&P 500 over the long term, despite PSUS losing approximately 17% from its IPO price, closing at $41.30 last Friday.
- Investment Outlook: Jefferies sees PSUS's long-term net returns bolstered by the absence of a performance fee, improvement in net asset value after full investment of the portfolio, and increased liquidity, while the fund's strong marketability due to its manager and portfolio adds to its appeal.
- Capital Structure Analysis: Jefferies rates PS as Hold with a $40 price target, noting that analyst Daniel Fannon highlights the firm's capital base as structurally different from other traditional and alternative asset managers, with about 96% of its fee-paying capital classified as permanent, indicating a balanced risk/reward profile.
See More











